Everson L.A. Artifon, MD, FASGE from the Department of Surgery at the University of Sao Paulo in Sao Paulo, Brazil discusses his Original Article “Hepaticogastrostomy or choledochoduodenostomy for distal malignant biliary obstruction after failed ERCP: Is there any difference?”
The study demonstrated that both hepaticogastrostomy (HG) and choledochoduodenostomy (CDT) are feasible to create an EUS-guided fistula in those cases with failed ERCP and distal malignant cancer.
This is the first prospective study comparing both techniques.
Regarding technical and clinical success, quality of life, adverse events, and survival, it was demonstrated that all domains had no statistical difference.
Further multicenter and larger studies are needed to validate this trend.
Figure 1. Overall flow diagram of patients allocation. RV, rendezvous; HPG, hepaticogastrostomy; CD, choledochoduodenostomy; PTS, patients.
Find the article abstract online.
The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.